Keyword: Dechra Pharmaceutical
The U.K.’s Dechra Pharmaceuticals has been on an acquisition binge over the last year. Now it’s expanding its geographic footprint even further, picking up Australia’s Apex Laboratories for AU$55 million ($41.2 million).
U.K.-based Dechra Pharmaceuticals has spent much of the past year rolling out a global expansion plan that's largely focused on increasing its presence in North America, while also gaining a foothold in the growing market for drugs to treat food animals. On Feb. 22, the company announced that results in the first half of its fiscal 2016 indicate it is well on its way to meeting those goals.